Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CARBOPROST TROMETHAMINE INJECTION, USP DIN 02530430

Status: Marketed
Holder: DR REDDY'S LABORATORIES LTD
Molecule: CARBOPROST (CARBOPROST TROMETHAMINE)
Available to quote

Health Canada record

Active ingredient(s)CARBOPROST (CARBOPROST TROMETHAMINE) 250 MCG
Dosage formSolution
RouteIntramuscular
SchedulePRESCRIPTION
ClassHuman
ATCG02AD04 CARBOPROST
Original market date16-May-2023
Current status date16-May-2023
SourceHealth Canada DPD

Establishment licence of the holder

Dr Reddy's Laboratories (UK) Limited — licence , not currently licensed, last inspection rating C (2019-02-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CARBOPROST (CARBOPROST TROMETHAMINE)

DINProductCompanyFormStrengthStatus
02546779CARBOPROST TROMETHAMINE INJECTIONJAMP PHARMA CORPORATIONSolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed
02538377CARBOPROST TROMETHAMINE INJECTION USPJUNO PHARMA CANADA INC.SolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed
02553856CARBOPROST TROMETHAMINE INJECTION, USPDR REDDY'S LABORATORIES LTDSolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGApproved
02230417HEMABATEPFIZER CANADA ULCSolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed

Notices of Compliance

NOCDateSubmissionReason
288752022-09-02Abbreviated New Drug Submission (ANDS)
Request a quote for CARBOPROST TROMETHAMINE INJECTION, USP

How to read a Canadian DIN record